Keith A A Fox

Keith A A Fox

UNVERIFIED PROFILE

Are you Keith A A Fox?   Register this Author

Register author
Keith A A Fox

Keith A A Fox

Publications by authors named "Keith A A Fox"

Are you Keith A A Fox?   Register this Author

100Publications

2581Reads

-Profile Views

The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI population.

Int J Cardiol 2019 Mar 3;278:7-13. Epub 2018 Dec 3.

Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou (HEGP), Department of Cardiology, Paris, France; Université Paris-Descartes, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2018.11.138DOI Listing
March 2019

Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis).

Am J Cardiol 2019 Feb 6;123(3):355-360. Epub 2018 Nov 6.

Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2018.10.033DOI Listing
February 2019

Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention.

Circ Cardiovasc Interv 2019 Feb;12(2):e007124

Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (M.K., M.K.Y., T.N., C.M.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.118.007124DOI Listing
February 2019

Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study.

J Am Coll Cardiol 2019 Jan;73(2):121-130

Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07351097183906
Publisher Site
http://dx.doi.org/10.1016/j.jacc.2018.10.048DOI Listing
January 2019

Association between time of hospitalization with acute myocardial infarction and in-hospital mortality.

Eur Heart J 2019 Jan 29. Epub 2019 Jan 29.

Department of Clinical and Population Sciences, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehy835DOI Listing
January 2019

Oral anticoagulant use in cardiovascular disorders: a perspective on present and potential indications for rivaroxaban.

Curr Med Res Opin 2018 Nov 21;34(11):1945-1957. Epub 2018 May 21.

b Centre for Cardiovascular Science , University of Edinburgh and Royal Infirmary of Edinburgh , Edinburgh , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2018.1467885DOI Listing
November 2018

Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial).

Am J Cardiol 2018 Oct 19;122(8):1322-1329. Epub 2018 Jul 19.

Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2018.06.052DOI Listing
October 2018

Early discontinuation of prasugrel or clopidogrel in acute coronary syndromes: insights from the TRILOGY ACS trial.

Coron Artery Dis 2018 Sep;29(6):469-476

Department of Medicine, Division of Cardiology, St Michael's Hospital, Toronto, Ontario.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCA.0000000000000623DOI Listing
September 2018

Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events).

Am J Cardiol 2018 Sep 21;122(6):944-951. Epub 2018 Jun 21.

Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Women's College Research Institute, Toronto, Ontario, Canada; Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada; Cardiovascular Division, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2018.06.001DOI Listing
September 2018

Strengths and weaknesses of 'real-world' studies involving non-vitamin K antagonist oral anticoagulants.

Open Heart 2018 21;5(1):e000788. Epub 2018 Apr 21.

Centre for Cardiovascular Science, University of Edinburgh and Royal Infirmary of Edinburgh, Edinburgh, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/openhrt-2018-000788DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922572PMC
April 2018

Electrocardiographic Findings in Patients With Acute Coronary Syndrome Presenting With Out-of-Hospital Cardiac Arrest.

Am J Cardiol 2018 Feb 3;121(3):294-300. Epub 2017 Nov 3.

St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2017.10.030DOI Listing
February 2018

Challenges in comparing the non-vitamin K antagonist oral anticoagulants for atrial fibrillation-related stroke prevention.

Europace 2018 01;20(1):1-11

Duke Clinical Research Institute, Duke University School of Medicine, 2400 Pratt Street, Durham, NC 27705, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/eux086DOI Listing
January 2018

GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome.

Int J Cardiol 2017 Oct 15;244:24-29. Epub 2017 Jun 15.

University of Toronto, Toronto, ON, Canada; Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, Canadian Heart Research Centre, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2017.06.055DOI Listing
October 2017

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

N Engl J Med 2017 10 27;377(14):1319-1330. Epub 2017 Aug 27.

From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (J.W.E., S.J.C., J.B., R.G.H., O.S., E.M.L., S.S.A., D.L., S.Y.), and Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, QC (G.R.D.) - both in Canada; Estudios Clínicos Latino América and Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Amphia Ziekenhuis and Werkgroep Cardiologische Centra Nederland (WCN), Utrecht, the Netherlands (M.A.); Cardiocenter, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic (P.W.); Osaka International Cancer Institute, Osaka, Japan (M.H.); Instituto Dante Pazzanese de Cardiologia (A.A.), and Hospital do Coração (L.S.P.), São Paulo; University of Washington Medical Center (K.R.H.B.) and University of Washington (J.P.), Seattle; Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston (D.L.B.); FuWai Hospital, Beijing (J.Z., Y.L.); National Association of Hospital Cardiologists Research Center (ANMCO), Florence, Italy (A.P.M.); Research Institute, Fundación Oftalmológica de Santander (FOSCAL)-Bucaramanga, Bucaramanga, Colombia (P.L.-J.); National University of Ireland, Galway (M.O.); Thrombosis Research Institute and University College London, London (A.K.K.), Centre for Cardiovascular Science, University of Edinburgh, Edinburgh (K.A.A.F.), and University of Glasgow, Glasgow (T.J.G.) - all in the United Kingdom; Collegium Medicum Jagiellonian University, Krakow, Poland (T.J.G); Institute of Cardiology, Kiev, Ukraine (A.N.P.); University of Würzburg and University Hospital, Würzburg (G.E., S.S.), and Bayer, Leverkusen (N.C.B., F.M., E.C.) - all in Germany; Semmelweis University, Budapest, Hungary (M.K.); Karolinska Institutet, Stockholm (L.R.); National Research Center for Preventative Medicine, Moscow (N.P.); University of Philippines, Manila (A.L.D.); Universidad de La Frontera, Temuco, Chile (F.L.); University of Cape Town, Cape Town, South Africa (P.J.C.); University of Aalborg, Copenhagen (C.T.-P.); University of Leuven, Leuven, Belgium (P.B.V.); University of Medicine and Pharmacology, Carol Davila University and Emergency Hospital, Bucharest, Romania (D.V.); Catholic University of Korea, Seoul, South Korea (J.-H.K.); Monash University, Melbourne, VIC, Australia (A.M.T.); Lady Davis Carmel Medical Center, Haifa, Israel (B.S.L.); Facultad de Ciencias de la Salud Eugenio Espejo-Universidad Tecnológica Equinoccial, Quito, Ecuador (C.F.); Universiti Teknologi Mara, Selangor, Malaysia (K.Y.); Université Paris Diderot, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris (P.G.S.); and Turku University Central Hospital and Turku University, Turku, Finland (K.P.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709118DOI Listing
October 2017

Erratum.

Eur Heart J Qual Care Clin Outcomes 2017 10;3(4):328

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjqcco/qcx024DOI Listing
October 2017

Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome.

Clin Chem 2017 Jul 17;63(7):1214-1226. Epub 2017 May 17.

The 3rd Medical Department, Cardiology and Intensive Care Medicine, Wilhelminenhospital and Sigmund Freud Private University, Medical School, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2016.265272DOI Listing
July 2017

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.

J Am Coll Cardiol 2017 Jun;69(22):2710-2720

Medical Research Council Bioinformatics Centre, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; Department of Cardiology, York Teaching Hospital NHS Foundation Trust, York, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2017.03.578DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457288PMC
June 2017

Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization.

Am Heart J 2017 Jun 27;188:156-166. Epub 2017 Mar 27.

Duke Clinical Research Institute, Durham, NC, USA; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2017.03.015DOI Listing
June 2017

Assessment of Quality Indicators for Acute Myocardial Infarction in the FAST-MI (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) Registries.

Circ Cardiovasc Qual Outcomes 2017 Jun;10(6)

From the Department of Cardiology, University Hospital of Besancon, EA3920 University of Franche-Comté, France (F.S., N.M.); Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, and York Teaching Hospital NHS Foundation Trust, United Kingdom (C.P.G.); Department of Clinical Pharmacology, Unite de Recherche Clinique de l'Est Parisien, Assistance Publique-Hôpitaux de Paris, Saint Antoine Hospital, France; Université Pierre et Marie Curie, Paris, France (T.S.); Centre for Cardiovascular Science, University and Royal Infirmary of Edinburgh, United Kingdom (K.A.A.F.); Centro Nacional de Investigaciones Cardiovasculares (CNIC), Cardiology Department, Hospital Universitario 12 de Octubre, and Universidad Complutense de Madrid, Spain (H.B.); Cardiovascular Department, Humanitas Research Hospital, Milan, Italy (M.L.); Department of Cardiology, Ospedale San Filippo Neri, Rome, Italy (M.T.); Assistance Publique-Hôpitaux de Paris (AP-HP); Hôpital Européen Georges Pompidou (HEGP), Department of Cardiology, Paris, France; Université Paris-Descartes, Paris, France (E.P., N.D.); and Department of Cardiology, Toulouse University School of Medicine, Rangueil Hospital, France (J.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.116.003336DOI Listing
June 2017

Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome.

Am Heart J 2017 May 21;187:194-203. Epub 2017 Feb 21.

Duke Clinical Research Institute, Durham, NC; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2017.01.016DOI Listing
May 2017

Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).

Circ Cardiovasc Qual Outcomes 2017 05;10(5)

From the Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.O., D.W., W.S.J., M.R.P.); Department of Statistics, North Carolina State University, Raleigh (D.H.); Mount Sinai Medical Center, New York, NY (J.L.H.); Department of Cardiovascular Medicine, Hospital of the University of Münster, Germany (G.B.); Massachusetts General Hospital and Harvard Medical School, Boston (D.E.S.); University of Edinburgh and Royal Infirmary of Edinburgh, Scotland, United Kingdom (K.A.A.F.); School of Medicine and Pharmacology, University of Western Australia, Crawley (G.J.H.); and Stanford University School of Medicine, CA (K.W.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.116.003520DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485838PMC
May 2017

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.

N Engl J Med 2017 05;376(20):1933-1942

From the Cleveland Clinic Coordinating Center for Clinical Research (C5Research), Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland (A.M.L., V.M., E.M., K.W., D.M., S.E.N.); South Australian Heart and Medical Research Institute, University of Adelaide, Adelaide (S.J.N.), and School of Medical Sciences, University of New South Wales, Sydney (P.J.B.) - both in Australia; Eli Lilly, Indianapolis (J.S.R., G.R., B.V., G.W.); Washington Cardiovascular Associates, Medstar Research Institute, Washington, DC (H.B.B.); Centre for Cardiovascular Science, University of Edinburgh, Edinburgh (K.A.A.F.); Beth Israel Deaconess Medical Center, Boston (C.M.G.); Duke University Medical Center, Durham, NC (C.G.); Université Sorbonne Paris 6, ACTION Study Group, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Institut de Cardiologie, Paris (G.M.); Penn Heart and Vascular Center, Philadelphia (D.R.); Columbia University, New York (A.R.T.), and Saratoga Cardiology Associates, Saratoga Springs (D.K.) - both in New York; St. Michael's Hospital, Toronto (S.G.), Recherche Médicale Saint-Jérôme, Saint-Jérôme, QC (Y.P.), and Centre de Santé et de Services Sociaux du Nord de Lanaudière-Centre Hospitalier Régional de Lanaud, Saint-Charles-Borromée, QC (S.K.) - all in Canada; Instituto Cardiovascular de Buenos Aires, Buenos Aires (D.C.); University of Texas Southwestern Medical Center, Dallas (D.K.M.); Heart Institute (InCor)-University of São Paulo Medical School, São Paulo (J.C.N.); Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosi, Mexico (J.L.L.-P.); the First Affiliated Hospital of Harbin Medical University, Harbin, China (W.L.); and South Oklahoma Heart Research, Oklahoma City (N.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1609581DOI Listing
May 2017

Evolving quality standards for large-scale registries: the GARFIELD-AF experience.

Eur Heart J Qual Care Clin Outcomes 2017 04;3(2):114-122

Thrombosis Research Institute, Emmanuel Kaye Building, Manresa Road, Chelsea, London SW3 6LR, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjqcco/qcw058DOI Listing
April 2017

Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis.

Circulation 2017 03;135(10):1001-1003

From Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (S.M.L., C.B.F., A.S.H., Y.L., J.P.P., M.R.P.); Division of Cardiology, University of British Columbia, Vancouver, Canada (C.B.F.); Department of Cardiovascular Medicine, University of Münster, Germany (G.B.); Stanford University School of Medicine, CA (K.W.M.); Massachusetts General Hospital and Harvard Medical School, Boston (D.E.S.); Ruprecht-Karls-University, Heidelberg, Germany (W.H.); Cardiovascular Institute, Mount Sinai Medical Center, NY (J.L.H.); School of Medicine and Pharmacology, The University of Western Australia, Crawley (G.J.H.); Bayer HealthCare Pharmaceuticals, Parsippany, NJ (S.D.B.); Janssen Research and Development LLC, Raritan, NJ (C.C.N.); University of Cincinnati College of Medicine, OH (R.C.B.); and University of Edinburgh and Royal Infirmary of Edinburgh, UK (K.A.A.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024666DOI Listing
March 2017

Total Center Percutaneous Coronary Intervention Volume and 30-Day Mortality: A Contemporary National Cohort Study of 427 467 Elective, Urgent, and Emergency Cases.

Circ Cardiovasc Qual Outcomes 2017 03;10(3)

From the Research Department of Epidemiology and Public Health, University College London, United Kingdom (D.O., O.N.); Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (C.P.G.); Department of Cardiology, York Teaching Hospital, United Kingdom (C.P.G.); Queen Elizabeth Hospital, Birmingham, United Kingdom (P.L.); The James Cook University Hospital, Middlesbrough, United Kingdom (M.A.d.B.); NIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, United Kingdom (A.T.); Centre for Cardiovascular Science, University of Edinburgh, United Kingdom (K.A.A.F.); Wessex Cardiac Unit, University Hospital Southampton, United Kingdom (I.A.S.); King's College London/St Thomas' Hospital, United Kingdom (S.R.); University Hospitals of South Manchester, United Kingdom (S.G.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.116.003186DOI Listing
March 2017

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.

Circulation 2017 Jan 14;135(4):323-333. Epub 2016 Nov 14.

From Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C.M.G., D.S.P., G.C., D.A., M.Y., S.K., Y.D., P.J.); Cardiovascular Institute, Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai, New York (R.M., J.H.); Heart Center, Department for Cardiology and Angiology I, University of Freiburg, Freiburg, Germany (C.B.); Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands (F.W.A.V.); Janssen Pharmaceuticals, Inc, Beerse, Belgium (P.W., P.B.); Bayer Pharmaceuticals, Inc, Berlin, Germany (M.v.E.); University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.); Division of Cardiology, Newark Beth Israel Medical Center, Newark, NJ (M.C.); Duke Clinical Research Institute, Durham, NC (E.D.P.); and Centre for Cardiovascular Science, University of Edinburgh and Royal Infirmary of Edinburgh, Edinburgh, United Kingdom (K.A.A.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025783DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266420PMC
January 2017

Temporal trends in all-cause mortality according to smoking status: Insights from the Global Registry of Acute Coronary Events.

Int J Cardiol 2016 Sep 15;218:291-297. Epub 2016 May 15.

St. Michael's Hospital, University of Toronto, Toronto, Canada; Canadian Heart Research Centre, Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2016.05.064DOI Listing
September 2016

Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non-ST-Elevation Myocardial Infarction, 2003-2013.

JAMA 2016 Sep;316(10):1073-82

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, England14York Teaching Hospital NHS Foundation Trust, York, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2016.10766DOI Listing
September 2016

Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial.

Am Heart J 2016 09 22;179:77-86. Epub 2016 Jun 22.

Duke Clinical Research Institute, Durham, NC; Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2016.05.019DOI Listing
September 2016

On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.

Circulation 2016 Jul;134(1):37-47

From Duke Clinical Research Institute, Durham, NC (C.B.F., A.S.H., Y.L., S.M.L., J.P.P., M.R.P.); University of Cincinnati College of Medicine, OH (R.C.B.); Bayer HealthCare Pharmaceuticals, Whippany, NJ (S.D.B); Department of Cardiovascular Medicine, Division of Electrophysiology, University Hospital Münster, Germany (G.B.); Centre for Cardiovascular Science, University of Edinburgh and Royal Infirmary of Edinburgh, UK (K.A.A.F.); Department of Medicine, Stanford University, CA (K.W.M.); Janssen Research and Development, Raritan, NJ (C.C.N.); and Massachusetts General Hospital and Harvard Medical School, Boston (D.E.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.021890DOI Listing
July 2016

Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".

Circulation 2016 Jul;134(2):e7-8

From the Duke Clinical Research Institute (J.P.P., A.S.H., M.R.P.) and Duke Heart Center (J.P.P., J.B.W., M.R.P.), Duke University Medical Center, Durham, NC; University of Cincinnati College of Medicine, Cincinnati, OH (R.C.B.); Hospital of the University of Münster, Germany (G.B.); Bayer HealthCare Pharmaceuticals, Parsippany, NJ (S.D.B.); Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, NY (J.L.H.); School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia (G.J.H.); Ruprecht-Karls-University, Heidelberg, Germany (W.H.); Department of Medicine, Stanford University, CA (K.W.M.); Janssen Pharmaceutical Research and Development, Raritan, NJ (C.C.N.); Massachusetts General Hospital, and Harvard Medical School, Boston (D.E.S.); and University of Edinburgh and Royal Infirmary of Edinburgh, UK (K.A.A.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.022737DOI Listing
July 2016

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.

N Engl J Med 2016 07 6;375(4):390-1. Epub 2016 Jul 6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1604020DOI Listing
July 2016

Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial.

Stroke 2016 Apr 16;47(4):1135-9. Epub 2016 Feb 16.

From the Cardiology Department, National Heart Centre Singapore, and Duke-NUS Graduate Medical School, Singapore (C.T.C.); Duke Clinical Research Institute, Durham, NC (B.N., E.M.O., M.T.R.); Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC (E.M.O., M.T.R.); Department of Medicine, Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada (P.W.A.); Department of Cardiovascular Diseases, Pontificia Universidad Católica de Chile, Santiago, Chile (R.C.); Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Centre for Chronic Disease Control and Public Health Foundation of India, New Delhi, India (D.P.); Eli Lilly and Company, Indianapolis, IN (K.J.W.); Centre for Cardiovascular Science, University of Edinburgh, and Royal Infirmary of Edinburgh, Edinburgh, United Kingdom (K.A.A.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.115.012454DOI Listing
April 2016

Clinical Characteristics, Management, and Outcomes of Acute Coronary Syndrome in Patients With Right Bundle Branch Block on Presentation.

Am J Cardiol 2016 Mar 12;117(5):754-9. Epub 2015 Dec 12.

Terrence Donnelly Heart Centre, Department of Medicine, St Michael's Hospital, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2015.12.005DOI Listing
March 2016

Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial.

J Am Coll Cardiol 2016 Mar;67(11):1289-97

Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2016.01.034DOI Listing
March 2016

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.

N Engl J Med 2016 Feb 3;374(8):785-8. Epub 2016 Feb 3.

University of Edinburgh, Edinburgh, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1515842DOI Listing
February 2016

Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation.

Circulation 2016 Jan 16;133(4):352-60. Epub 2015 Dec 16.

From Duke Clinical Research Institute, Durham, NC (J.P.P., A.S.H., M.R.P.); Duke Heart Center, Duke University Medical Center, Durham, NC (J.P.P., J.B.W., M.R.P.); University of Cincinnati College of Medicine, OH (R.C.B.); Hospital of the University of Münster, Germany (G.B.); Bayer HealthCare Pharmaceuticals, Whippany, NJ (S.D.B.); Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, NY (J.L.H.); School of Medicine and Pharmacology, University of Western Australia, Crawley, WA (G.J.H.); Ruprecht-Karls-University, Heidelberg, Germany (W.H.); Department of Medicine, Stanford University, Palo Alto, CA (K.W.M.); Janssen Pharmaceutical Research and Development, Raritan, NJ (C.C.N.); Massachusetts General Hospital and Harvard Medical School, Boston (D.E.S.); and University of Edinburgh and Royal Infirmary of Edinburgh, UK (K.A.A.F.).

View Article

Download full-text PDF

Source
https://circ.ahajournals.org/content/early/2015/12/16/CIRCUL
Web Search
http://circ.ahajournals.org/content/early/2015/12/16/CIRCULA
Web Search
http://circ.ahajournals.org/lookup/doi/10.1161/CIRCULATIONAH
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.018544DOI Listing
January 2016

Atherosclerosis stabilization with PCSK-9 inhibition: An evolving concept for cardiovascular prevention.

Atherosclerosis 2015 Dec 23;243(2):593-7. Epub 2015 Oct 23.

Edinburgh University, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2015.10.023DOI Listing
December 2015